← Evidence map

ArticleAntimicrobial agents and chemotherapy2021

Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola.

Victoria C Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34252308